Lukas, Rimas V.
Wainwright, Derek A.
Horbinski, Craig M.
Iwamoto, Fabio M.
Sonabend, Adam M.
Funding for this research was provided by:
National Cancer Institute (P50CA221747, P50CA221747, P50CA221747, P50CA221747)
BrainUp (2136)
Article History
First Online: 9 October 2019
Compliance with Ethical Standards
:
: RVL, DAW, CMH, AMS are supported by P50CA221747 SPORE for Translational Approaches to Brain Tumours. DAW and RVL are supported by BrainUp grant 2136.
: RVL has received honoraria for serving on advisory boards for Monteris and Ziopharm. RVL, CMH, AMS, and FMI have received honoraria as consultants for Abbvie. FMI has received honoraria for consulting for Merck, Novocure, Tocagen, Alexion, and Regeneron. RVL has received support from Roche for travel to present at a meeting. FMI has received travel support to FDA meeting from Merck. FMI has received funding for research support for investigator-initiated trials from Merck, BMS, and Novocure. RVL have received honoraria for medical editing from Medlink Neurolology, medical review of content for EBSCO Publishing, and creating/presenting board review material for American Physician Institute.